TRAVERSE CITY, MI – America’s first national healthcare center specializing in the treatment of long COVID is opening this ...

Nirmatrelvir-ritonavir reduced the risk for long COVID in adults aged 50 years and older but not in adolescents.

Many long-COVID symptoms in people older than 65 years mimic signs of early aging, particularly cognitive, cardiac, and ...

Despite the mechanisms that made it a “biologically plausible” candidate, the study found that participants who took the drug ...

According to the World Health Organization, for every 100 people infected, 6 developed long COVID. One of the most common and ...

Long COVID remains globally prevalent following COVID-19 infection, with a significant burden of symptoms lasting 1 to 2 years postinfection.

Early metformin initiation after COVID-19 infection is associated with a substantially lower 1-year risk for long COVID in adults with overweight or obesity, according to study results published in ...

A new study of Australians suffering from long COVID found 56% still had persistent symptoms six months after their initial ...

RFK Jr. has shut down the Office of Long COVID Research and Practice, gutted funding, and derailed trials and studies.

Editor's note: Find the latest long COVID news and guidance in Medscape's Long COVID Resource Center. Enrollment is opening for four clinical trials to evaluate new treatments for long COVID, the ...

A BMJ investigation shows patients spend a lot to likely benefit little. This is a MedPage Today story. With long COVID patients becoming increasingly frustrated with the lack of available treatments, ...